CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 189 filers reported holding CRISPR THERAPEUTICS AG in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,571,387 | -15.5% | 158,700 | +6.6% | 0.01% | -14.3% |
| Q1 2024 | $10,149,024 | +9.0% | 148,900 | +0.1% | 0.01% | 0.0% |
| Q4 2023 | $9,308,620 | +24.4% | 148,700 | -9.8% | 0.01% | +16.7% |
| Q3 2023 | $7,480,272 | -18.1% | 164,800 | +1.3% | 0.01% | 0.0% |
| Q2 2023 | $9,133,978 | +25.8% | 162,700 | +1.4% | 0.01% | +20.0% |
| Q1 2023 | $7,259,415 | -0.2% | 160,500 | -10.3% | 0.01% | 0.0% |
| Q4 2022 | $7,276,350 | -36.2% | 179,000 | +2.6% | 0.01% | -37.5% |
| Q3 2022 | $11,404,000 | +8.6% | 174,500 | +1.0% | 0.01% | +14.3% |
| Q2 2022 | $10,501,000 | +15.6% | 172,800 | +19.4% | 0.01% | +40.0% |
| Q1 2022 | $9,083,000 | -10.6% | 144,700 | +8.0% | 0.01% | -16.7% |
| Q4 2021 | $10,155,000 | -32.3% | 134,000 | 0.0% | 0.01% | -40.0% |
| Q3 2021 | $14,999,000 | -30.3% | 134,000 | +0.8% | 0.01% | -23.1% |
| Q2 2021 | $21,531,000 | +30.8% | 133,000 | -1.6% | 0.01% | +18.2% |
| Q1 2021 | $16,462,000 | -9.6% | 135,100 | +13.5% | 0.01% | -15.4% |
| Q4 2020 | $18,220,000 | +87.3% | 119,000 | +2.3% | 0.01% | +62.5% |
| Q3 2020 | $9,727,000 | +49.9% | 116,300 | +31.7% | 0.01% | +60.0% |
| Q2 2020 | $6,489,000 | +162.4% | 88,300 | +51.5% | 0.01% | +66.7% |
| Q1 2020 | $2,473,000 | -22.4% | 58,300 | +11.5% | 0.00% | 0.0% |
| Q4 2019 | $3,185,000 | +57.0% | 52,300 | +5.7% | 0.00% | +50.0% |
| Q3 2019 | $2,029,000 | -11.4% | 49,500 | +1.9% | 0.00% | 0.0% |
| Q2 2019 | $2,289,000 | +69.6% | 48,600 | +28.6% | 0.00% | +100.0% |
| Q1 2019 | $1,350,000 | +39.8% | 37,800 | +11.8% | 0.00% | 0.0% |
| Q4 2018 | $966,000 | -35.6% | 33,800 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $1,499,000 | -22.2% | 33,800 | +3.0% | 0.00% | 0.0% |
| Q2 2018 | $1,927,000 | – | 32,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
| Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
| EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
| NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
| ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
| NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
| Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
| Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |